GB2146529A - Oral dobutamine preparation - Google Patents
Oral dobutamine preparation Download PDFInfo
- Publication number
- GB2146529A GB2146529A GB08423485A GB8423485A GB2146529A GB 2146529 A GB2146529 A GB 2146529A GB 08423485 A GB08423485 A GB 08423485A GB 8423485 A GB8423485 A GB 8423485A GB 2146529 A GB2146529 A GB 2146529A
- Authority
- GB
- United Kingdom
- Prior art keywords
- dobutamine
- preparation
- active ingredient
- plasma
- administration
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Cardiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Organic Chemistry (AREA)
- Hospice & Palliative Care (AREA)
- Heart & Thoracic Surgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Epidemiology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP58171594A JPS6061523A (ja) | 1983-09-16 | 1983-09-16 | 経口用ドブタミン製剤 |
Publications (2)
Publication Number | Publication Date |
---|---|
GB8423485D0 GB8423485D0 (en) | 1984-10-24 |
GB2146529A true GB2146529A (en) | 1985-04-24 |
Family
ID=15926052
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB08423485A Withdrawn GB2146529A (en) | 1983-09-16 | 1984-09-17 | Oral dobutamine preparation |
Country Status (5)
Country | Link |
---|---|
JP (1) | JPS6061523A (it) |
DE (1) | DE3433678A1 (it) |
FR (1) | FR2551974A1 (it) |
GB (1) | GB2146529A (it) |
IT (1) | IT1179127B (it) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4663351A (en) * | 1985-08-23 | 1987-05-05 | Berlex Laboratories, Inc. | Dobutamine tri-isobutyric acid ester and the use thereof as a cardiotonic agent |
EP0476846A2 (en) * | 1990-08-27 | 1992-03-25 | Eli Lilly And Company | Method for treating imflammation, ischemia-induced cell damage and muscular dystrophy |
US5280046A (en) * | 1991-02-22 | 1994-01-18 | The University Of Colorado Foundation, Inc. | Method of treating type I diabetes |
US5552439A (en) * | 1990-08-27 | 1996-09-03 | Eli Lilly And Company | Method of treating inflammatory bowel disease |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1392674A (en) * | 1972-04-12 | 1975-04-30 | Lilly Co Eli | Dopamine derivatives |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1453034A (en) * | 1972-12-15 | 1976-10-20 | Boehringer Sohn Ingelheim | Pharmaceutical composition for treating spasticity |
NZ196349A (en) * | 1980-03-07 | 1984-08-24 | Interx Research Corp | Enhancement of absorption rate of orally administered polar bioactive agents |
-
1983
- 1983-09-16 JP JP58171594A patent/JPS6061523A/ja active Pending
-
1984
- 1984-09-12 FR FR8413998A patent/FR2551974A1/fr active Pending
- 1984-09-13 DE DE19843433678 patent/DE3433678A1/de not_active Withdrawn
- 1984-09-14 IT IT67927/84A patent/IT1179127B/it active
- 1984-09-17 GB GB08423485A patent/GB2146529A/en not_active Withdrawn
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1392674A (en) * | 1972-04-12 | 1975-04-30 | Lilly Co Eli | Dopamine derivatives |
Non-Patent Citations (1)
Title |
---|
MARTINDALE }THE EXTRA PHARMACOPOEIA}, DECEMBER 1982, THE PHARMACEUTICAL PRESS * |
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4663351A (en) * | 1985-08-23 | 1987-05-05 | Berlex Laboratories, Inc. | Dobutamine tri-isobutyric acid ester and the use thereof as a cardiotonic agent |
EP0476846A2 (en) * | 1990-08-27 | 1992-03-25 | Eli Lilly And Company | Method for treating imflammation, ischemia-induced cell damage and muscular dystrophy |
EP0476846A3 (en) * | 1990-08-27 | 1992-08-05 | Eli Lilly And Company | Method for treating imflammation, ischemia-induced cell damage and muscular dystrophy |
US5281623A (en) * | 1990-08-27 | 1994-01-25 | Eli Lilly And Company | Method for treating inflammation |
US5393786A (en) * | 1990-08-27 | 1995-02-28 | Eli Lilly And Company | Method for treating inflammation, ischemia-induced cell damage and muscular dystrophy |
US5552439A (en) * | 1990-08-27 | 1996-09-03 | Eli Lilly And Company | Method of treating inflammatory bowel disease |
US5280046A (en) * | 1991-02-22 | 1994-01-18 | The University Of Colorado Foundation, Inc. | Method of treating type I diabetes |
Also Published As
Publication number | Publication date |
---|---|
IT1179127B (it) | 1987-09-16 |
FR2551974A1 (fr) | 1985-03-22 |
IT8467927A0 (it) | 1984-09-14 |
GB8423485D0 (en) | 1984-10-24 |
DE3433678A1 (de) | 1985-03-28 |
JPS6061523A (ja) | 1985-04-09 |
IT8467927A1 (it) | 1986-03-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US4556678A (en) | Sustained release propranolol tablet | |
JP6581625B2 (ja) | 代謝障害を治療するための組成物および方法 | |
KR910004572B1 (ko) | 경구용 당뇨병 치료제 제형의 제조방법 | |
US20220370366A1 (en) | Tablets containing cilofexor and pharmaceutically acceptable carriers | |
JP5698682B2 (ja) | トライアシル−3−ヒドロキシフェニルアデノシン及びその血中脂肪の調節用途 | |
CN111635309A (zh) | 一种新型解热镇痛药物及其制备方法和用途 | |
TWI327469B (en) | Pharmaceutical composition | |
CN111635315B (zh) | 一种解热镇痛药物及其制备方法和用途 | |
JPH0761923A (ja) | アルツハイマー病治療剤 | |
JPS625913A (ja) | ジヒドロピリジン含有製剤 | |
GB2146529A (en) | Oral dobutamine preparation | |
US6441041B1 (en) | (-)-hydroxycitric acid for the prevention of osteoporosis | |
JP2872695B2 (ja) | 腎炎の治療剤 | |
WO1996011682A1 (fr) | Composition preventive et remede pour les maladies allergiques de type i | |
Walter-Sack et al. | Disposition and uric acid lowering effect of oxipurinol: comparison of different oxipurinol formulations and allopurinol in healthy individuals | |
US11013707B2 (en) | Administration of oral methyldopa | |
Strisower et al. | PHYSIOLOGIC EFFECTS OF l-TRIIODOTHYRONLNE | |
JP3024789B2 (ja) | 血圧降下剤 | |
US5342853A (en) | Method of using nor-verapamil and nor-gallopamil as anti-arteriosclerotics | |
US4443469A (en) | Uric acid-lowering composition, method and use | |
EA006776B1 (ru) | Фармацевтическая композиция для лечения диабетической невропатии | |
WO2022144021A1 (zh) | Dorzagliatin和胰高血糖素样肽-1类似物的药物组合物 | |
JP2835547B2 (ja) | 糖尿病治療剤 | |
JPH09227371A (ja) | 粥状動脈硬化抑制剤 | |
JPH03291220A (ja) | アスコクロリン誘導体を有効成分とするCa代謝異常改善剤 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
WAP | Application withdrawn, taken to be withdrawn or refused ** after publication under section 16(1) |